Bit Capital Gmb H Ultragenyx Pharmaceutical Inc. Transaction History
Bit Capital Gmb H
- $1.26 Trillion
- Q4 2024
A detailed history of Bit Capital Gmb H transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Bit Capital Gmb H holds 29,870 shares of RARE stock, worth $1.3 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
29,870
Previous 29,870
-0.0%
Holding current value
$1.3 Million
Previous $1.66 Billion
24.27%
% of portfolio
0.1%
Previous 0.15%
Shares
4 transactions
Others Institutions Holding RARE
# of Institutions
333Shares Held
86.3MCall Options Held
520KPut Options Held
406K-
Vanguard Group Inc Valley Forge, PA10MShares$437 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$244 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.12MShares$223 Million0.91% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.07MShares$134 Million0.02% of portfolio
-
Alkeon Capital Management LLC New York, NY3.01MShares$131 Million0.29% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.05B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...